A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis.

ATTR cardiac amyloidosis Amyloid Japanese Circulation Society Japanese Ministry of Health, Labour and Welfare (JMHLW) Tafamidis

Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 12 2019
Historique:
pubmed: 19 11 2019
medline: 18 9 2020
entrez: 19 11 2019
Statut: ppublish

Résumé

Transthyretin cardiac amyloidosis is a progressive and life-threating disease that is significantly underdiagnosed, and the actual number of patients with the disease is presently unknown. Accumulation of wild-type transthyretin-derived amyloid in the heart is a common finding in very elderly patients. Recent clinical trials demonstrated that tafamidis reduced all-cause death and the number of cardiovascular hospitalizations when compared with placebo. The Japanese Ministry of Health, Labour and Welfare approved tafamidis (Vyndaqel

Identifiants

pubmed: 31735731
doi: 10.1253/circj.CJ-19-0811
doi:

Substances chimiques

Benzoxazoles 0
tafamidis 8FG9H9D31J

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-17

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Jin Endo (J)

Department of Cardiology, Keio University School of Medicine.

Motoaki Sano (M)

Department of Cardiology, Keio University School of Medicine.

Yasuhiro Izumiya (Y)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.

Kazufumi Nakamura (K)

Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.

Nobuhiro Tahara (N)

Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine.

Koichiro Kuwahara (K)

Department of Cardiovascular Medicine, Shinshu University School of Medicine.

Takayuki Inomata (T)

Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital.

Mitsuharu Ueda (M)

Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.

Yoshiki Sekijima (Y)

Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine.

Yukio Ando (Y)

Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.

Hiroyuki Tsutsui (H)

Department of Cardiovascular Medicine, Kyusyu University.

Mitsuaki Isobe (M)

Sakakibara Heart Institute.

Keiichi Fukuda (K)

Department of Cardiology, Keio University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH